The gene discovery efforts of Human Genome Sciences were successful.

Human Genome Sciences has three drugs in clinical trials derived from its database.

Human Genome Sciences paid for the work as part of a $10 million-a-year grant.

Human Genome Sciences has put in several, more than any other genomics company.

Human Genome Sciences is the latest company to announce work in biodefense.

Human Genome Sciences is a biopharmaceutical corporation founded in 1992.

Human Genome Sciences' wound-healing protein just failed to work in two clinical trials.

And Human Genome Sciences closed at $153, up $9.

But Human Genome Sciences, which already has drugs in clinical trials, is down only about 54 percent.

Human Genome Sciences rose 7 9/16, to 113 1/2.